Genmab Operating Income 2019-2024 | GMAB

Genmab operating income for the twelve months ending September 30, 2024 was $0.903B, a 1.32% decline year-over-year.

  • Genmab annual operating income for 2023 was $0.773B, a 14.17% decline from 2022.
  • Genmab annual operating income for 2022 was $0.9B, a 87.47% increase from 2021.
  • Genmab annual operating income for 2021 was $0.48B, a 50.35% decline from 2020.

Genmab Operating Income 2019-2024 | GMAB

  • Genmab annual operating income for 2023 was $0.773B, a 14.17% decline from 2022.
  • Genmab annual operating income for 2022 was $0.9B, a 87.47% increase from 2021.
  • Genmab annual operating income for 2021 was $0.48B, a 50.35% decline from 2020.